呼吸器感染症に対するKW-1070の臨床的検討 (KW-1070(FORTIMICIN)<特集>)
スポンサーリンク
概要
- 論文の詳細を見る
A clinical trial of KW-1070, a new aminoglycoside antibiotic, was carried out on 9 patients with respiratory tract infection including 4 acute pneumonia, 3 acute bronchopneumonia and 2 exacerbation of chronic bronchitis.<BR>KW-1070 was administered intramuscularly at a daily dose of 400 to 600mg.<BR>1. Clinical response of KW-1070 was excellent in 3 cases and good in 6 cases.<BR>2. Pathogens isolated before treatment from 8 cases were all eliminated.<BR>3. No adverse reaction was observed.
- 公益社団法人 日本化学療法学会の論文
公益社団法人 日本化学療法学会 | 論文
- DISPOSITION OF 7432-8 IN RATS (I)
- CLINICAL STUDIES ON T-1220 IN SURGICAL CASES
- CLINICAL STUDIES OF PIVALOYLOXYMETHYL D-α-AMINOBENZYL-PENICILLINATE HYDROCHLORIDE IN SURGICAL INFECTIONS
- STUDIES ON AC-1370
- Primary treatment with a combination of cyclophosphamide, vincristine, and dacarbazine for recurrent malignant pheochromocytoma: A case report.